Hong Kong stocks climb for second day as Japanese stocks drop

0 0

Asia-Pacific stocks increased Monday, Oct. 30, with the Hong Kong market climbing for the second session.

Hong Kong stocks were flat, with the Hang Seng Index
HSI,
-1.69%
flat at 17,406.36, while the Nikkei 225 Index
NIK,
+0.53%
of Japanese companies declined 1.0% to 30,696.96.

The Shanghai Composite Index
SHCOMP,
-0.09%
of Chinese companies rose 0.1% to 3,021.55, and The FTSE Straits Times Index
STI,
+0.06%
of Singapore stocks increased 0.1% to 3,066.23. South Korea’s KOSPI Composite Index
180721,
-1.41%
gained 0.3% to 2,310.55, while Australia’s S&P/ASX 200 Benchmark Index
XJO,
+0.12%
weakened 0.8% to 6,772.90.

Among Hang Seng Index constituents, optical instruments company Sunny Optical Technology
2382,
-5.41%
saw the largest increase Monday, as shares increased 6.5%.

Shares of pharmaceuticals firm Hansoh Pharmaceutical
3692,
-1.47%
and semiconductors company Semiconductor Mfg Intl
981,
-3.52%
gained 6.3% and 6.2%, respectively.

Shares of gas utilities company ENN Energy Holdings
2688,
+2.14%
saw the largest decline in Hong Kong, as shares fell 5.2% on Monday.

Shares of commercial banking firm China Merchants Bank
3968,
-1.65%
and oil and gas exploration company CNOOC
883,
-1.40%
weakened 3.8% and 3.5%, respectively.

Of the Nikkei 225 Index constituents, food products company Nisshin Seifun Group
2002,
+7.81%
saw the largest increase Monday, as shares surged 13.5%.

Shares of gas utilities firm Osaka Gas
9532,
+4.62%
and measuring/precision instruments company Keyence
6861,
+1.47%
added 10.0% and 8.0%, respectively.

Also in Japan, trucks/lorries/vans company Hino Motors
7205,
-0.09%
saw the largest decline Monday, as shares plunged 18.7%

Shares of environmental control systems firm Omron
6645,
+0.55%
and pharmaceuticals company Sumitomo Pharma
4506,
+7.53%
tumbled 15.8% and 11.3%, respectively.


Editor’s Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Read the full article here

Leave A Reply

Your email address will not be published.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy